AMN Healthcare Services

Day range

$46.50 – $48.19

Open

$46.50

Prev close

$46.82

Volume

920.6K

Market cap

$1.81B

Shares out

38.73M

P/E

17.28

P/S

0.53

P/B

2.45

P/FCF

4.13

ROE

14.1%

ROA

4.4%

Debt/Equity

1.00

Div yield

0.00%

As of Oct 22, 2026

• Shareholder meetingsMay 4, 2026

  At the Annual Meeting held on May 1, 2026, the Company's shareholders voted on five proposals as set forth below... The individuals listed below were elected at the Annual Meeting by the vote set forth in the table immediately below to serve as directors of the Company until the next annual meeting of shareholders or until their respective successors have been duly elected and qualified.

• Board of directorsFeb 5, 2026

  On January 30, 2026, R. Jeffrey Harris informed the Board of Directors (the "Board") of AMN Healthcare Services, Inc. (the "Company") of his decision to retire as a member of the Board effective as of the Company's 2026 annual meeting of shareholders (the "2026 Annual Meeting"). Therefore, Mr. Harris will not stand for re-election to the Board at the 2026 Annual Meeting.

• Investor communicationsJan 14, 2026

  The management of AMN Healthcare Services, Inc. (the "Company") will present at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. A slide presentation of materials to be presented at the conference is attached hereto as Exhibit 99.1 and will also be accessible via the Investor Relations section of the Company's website.

• Governance documentsDec 11, 2025

  On December 11, 2025, the Board of Directors of AMN Healthcare Services, Inc. adopted and approved amended and restated by-laws of the Company to, among other things: Align the By-laws with developments in Delaware law; Revise procedural mechanics and disclosure requirements applicable to stockholder-requested special meetings; Clarify the powers of the Board and the chair of a stockholder meeting to regulate conduct at a meeting; Revise procedural mechanics and disclosure requirements applicable to stockholder nominations of directors and submissions of proposals regarding other business at stockholder meetings.

• Debt activityOct 6, 2025

  On October 6, 2025, the Company and the Issuer entered into a Fifth Amendment (the "Fifth Amendment") to the existing Credit Agreement (as previously amended, the "Existing Credit Agreement," and as further amended by the Fifth Amendment, the "Credit Agreement"), dated as of February 9, 2018, by and among the Company, the Issuer, certain subsidiaries of the Company as guarantors, the several lenders party thereto from time to time (the "Lenders") and Truist Bank, as administrative agent. Pursuant to the Fifth Amendment, the Company's existing secured revolving credit facility was amended to (i) mature on October 6, 2030 (from February 2028), (ii) reduce the size of the facility from $750.0 million to $450.0 million.

• MEDPMedpace Holdings, Inc. Common Stock+2.33%
• VEEVVeeva Systems Inc.+0.15%
• WSTWest Pharmaceutical Services, Inc.-0.48%
• EYENational Vision Holdings, Inc. Common Stock-1.06%

Days to cover

5.8

Short interest

3.6M

Avg volume

626.12K

As of Sep 30, 2026 · reported to FINRA twice monthly.

• Strength Seen in AMN Healthcare (AMN): Can Its 8.9% Jump Turn into More Strength?
  neutralZacks Investment Research· Oct 23, 2026
• Here's Why You Should Retain AMN Stock in Your Portfolio for Now
  neutralZacks Investment Research· Oct 12, 2026
• Implied Volatility Surging for AMN Healthcare Stock Options
  neutralZacks Investment Research· Sep 15, 2026
• Here's Why You Should Retain AMN Stock in Your Portfolio for Now
  positiveZacks Investment Research· Sep 8, 2026
• Kelly Appoints Patrick McCall as Chief Growth Officer
  neutralGlobeNewswire Inc.· Feb 11, 2026